Search research articles
Contact Us
Filters
Showing results (61-70 of 99) with videos related to
Page
of 10
Sort By:
Annals of Surgical Oncology
|
August 3, 2017
Association of LN Evaluation with Survival in Women Aged 70 Years or Older With Clinically Node-Negative Hormone Receptor Positive Breast Cancer
Anees B Chagpar, Christos Hatzis, Lajos Pusztai, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 15, 2009
Genomic grade index is associated with response to chemotherapy in patients with breast cancer
Cornelia Liedtke, Christos Hatzis, William Fraser Symmans, et al.
Molecular Oncology
|
March 8, 2014
Global gene expression changes induced by prolonged cold ischemic stress and preservation method of breast cancer tissue
Bilge Aktas, Hongxia Sun, Hui Yao, et al.
F1000Research
|
July 14, 2016
Assessment of pharmacogenomic agreement
Zhaleh Safikhani, Nehme El-Hachem, Rene Quevedo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 20, 2015
Relationship between Complete Pathologic Response to Neoadjuvant Chemotherapy and Survival in Triple-Negative Breast Cancer
Christos Hatzis, W Fraser Symmans, Ya Zhang, et al.
The Oncologist
|
August 25, 2018
Long-Term Survival of De Novo Stage IV Human Epidermal Growth Receptor 2 (HER2) Positive Breast Cancers Treated with HER2-Targeted Therapy
Yao Wong, Akshara Singareeka Raghavendra, Christos Hatzis, et al.
Breast Cancer Research and Treatment
|
November 19, 2015
Prospective assessment of the decision-making impact of the Breast Cancer Index in recommending extended adjuvant endocrine therapy for patients with early-stage ER-positive breast cancer
Tara Sanft, Bilge Aktas, Brock Schroeder, et al.
BMC Cancer
|
February 5, 2021
Targeted RNAseq assay incorporating unique molecular identifiers for improved quantification of gene expression signatures and transcribed mutation fraction in fixed tumor samples
Chunxiao Fu, Michal Marczyk, Michael Samuels, et al.
Cancers
|
September 11, 2020
Multi-Omics Investigation of Innate Navitoclax Resistance in Triple-Negative Breast Cancer Cells
Michal Marczyk, Gauri A Patwardhan, Jun Zhao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 31, 2014
Gene signature-guided dasatinib therapy in metastatic breast cancer
Lajos Pusztai, Stacy Moulder, Mehmet Altan, et al.
Page
of 10
Search research articles
Search
Showing results (61-70 of 99) with videos related to
Sort By:
Page
of 10
Annals of Surgical Oncology
|
August 3, 2017
Association of LN Evaluation with Survival in Women Aged 70 Years or Older With Clinically Node-Negative Hormone Receptor Positive Breast Cancer
Anees B Chagpar, Christos Hatzis, Lajos Pusztai, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 15, 2009
Genomic grade index is associated with response to chemotherapy in patients with breast cancer
Cornelia Liedtke, Christos Hatzis, William Fraser Symmans, et al.
Molecular Oncology
|
March 8, 2014
Global gene expression changes induced by prolonged cold ischemic stress and preservation method of breast cancer tissue
Bilge Aktas, Hongxia Sun, Hui Yao, et al.
F1000Research
|
July 14, 2016
Assessment of pharmacogenomic agreement
Zhaleh Safikhani, Nehme El-Hachem, Rene Quevedo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 20, 2015
Relationship between Complete Pathologic Response to Neoadjuvant Chemotherapy and Survival in Triple-Negative Breast Cancer
Christos Hatzis, W Fraser Symmans, Ya Zhang, et al.
The Oncologist
|
August 25, 2018
Long-Term Survival of De Novo Stage IV Human Epidermal Growth Receptor 2 (HER2) Positive Breast Cancers Treated with HER2-Targeted Therapy
Yao Wong, Akshara Singareeka Raghavendra, Christos Hatzis, et al.
Breast Cancer Research and Treatment
|
November 19, 2015
Prospective assessment of the decision-making impact of the Breast Cancer Index in recommending extended adjuvant endocrine therapy for patients with early-stage ER-positive breast cancer
Tara Sanft, Bilge Aktas, Brock Schroeder, et al.
BMC Cancer
|
February 5, 2021
Targeted RNAseq assay incorporating unique molecular identifiers for improved quantification of gene expression signatures and transcribed mutation fraction in fixed tumor samples
Chunxiao Fu, Michal Marczyk, Michael Samuels, et al.
Cancers
|
September 11, 2020
Multi-Omics Investigation of Innate Navitoclax Resistance in Triple-Negative Breast Cancer Cells
Michal Marczyk, Gauri A Patwardhan, Jun Zhao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 31, 2014
Gene signature-guided dasatinib therapy in metastatic breast cancer
Lajos Pusztai, Stacy Moulder, Mehmet Altan, et al.
Page
of 10